key: cord-0705930-imt1poaw
authors: Hatipoglu, Suzan; Lyon, Alexander R.; Pennell, Dudley J.
title: CMR unveiling the cause of post CoVid-19 infection chest pain
date: 2021-01-28
journal: Int J Cardiovasc Imaging
DOI: 10.1007/s10554-021-02161-y
sha: 723045471a3efea76ffdc35550a5d8d7fbce6aca
doc_id: 705930
cord_uid: imt1poaw

nan

A 63 year old male presented with exercise induced chest pain 50 days after diagnosis of CoVid-19 infection (PCR positive) and was referred for cardiovascular magnetic resonance (CMR). Volumetric analysis showed high-normal indexed left ventricular volumes with low-normal ejection fraction of 60% (Supplementary Videos 1-4, 3 long axis views and short axis cine stack) and mild hypokinesia in the basal lateral wall. Native T1 values in the lateral wall were raised (1076 ms at 1.5 T, normal range 950-1050 ms, Panel A) and T2 values were borderline high (56 ms Panel B). Signal intensity was increased with a T2-short-tau-inversion-recovery sequence in the basal to mid lateral wall (Panels C and D, yellow arrows) with corresponding late gadolinium enhancement (Panels E and F, yellow arrow). Pericardial signal and thickness were normal with a small global pericardial effusion, but no CMR evidence of ventricular interdependence. There was no inducible myocardial ischaemia on perfusion imaging, with a normal global myocardial perfusion reserve of 2.8. Computed tomography (CT) pulmonary angiography was normal and there was non-obstructive atheroma on CT coronary angiography. Troponin and NT-pro BNP were normal, and d-dimer was elevated (930 ng/mL normal < 240).

The CMR findings were diagnostic for myocardial oedema and acute/subacute myocarditis without ischaemia infarction. The myocarditis was presumed to be immunemediated given the presentation after recovery from CoVid-19 and patient was empirically treated with oral steroids [1] . In repeat CMR after 2 weeks of treatment, tissue characterisation appearances were similar but wall motion abnormality in the basal lateral wall was no longer present and ejection fraction improved to 68%. This report highlights the clinical value of CMR to differentiate between possible causes of chest pain in CoVid-19 cases and demonstrates state-of-art symptom guided use in line with Society of Cardiovascular Magnetic Resonance recommendations [2] .

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. All authors meet the authorship criteria, work is not considered for publication or presentation elsewhere. All authors have read and agreed the final form of the manuscript.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons. org/licenses/by/4.0/.

SARS-CoV2-related myocarditis-like syndroms: Shakespeare's question: What's in a name?

Society for Cardiovascular Magnetic Resonance (SCMR) recommended CMR protocols for scanning patients with active or convalescent phase COVID-19 infection

The International Journal of Cardiovascular Imaging